This program funds research to create innovative high-function bio-pharmaceuticals by integrating foundational technologies like antibodies, peptides, nucleic acids, gene and cell therapies with drug delivery systems, efficacy and safety evaluation, and imaging. It aims to promote excellent drug discovery seeds and business development, accelerating clinical application and enhancing Japan's international competitiveness.
Eligibility criteria are not specified in the available information.
